- ►annals.org [PDF] AH Malik, WM Lee - Annals of internal medicine, 2000 - Am Coll Physicians Chronic hepatitis B virus (HBV) infection is a leading cause of cirrhosis and
hepatocellular carcinoma worldwide. Its prevalence approaches 10% in
hyperendemic areas, such as southeast Asia, China, and Africa. Although ... Cited by 177 - Related articles - BL Direct - All 4 versions
АХ Малик, УМ Ли - mediasphera.ru Хроническое носительство вируса гепатита В
(ВГВ) — основная причина развития цирроза и
гепатоцеллюлярной карциномы во всем ... Related articles
J Torresi, S Locarnini - Gastroenterology, 2000 - Elsevier Approximately 5% of the world's human population have an increased risk for
developing liver cancer and cirrhosis as a direct consequence of chronic
infection with the hepatitis B virus (HBV). Antiviral chemotherapy remains ... Cited by 117 - Related articles - BL Direct - All 11 versions
PM Rosenberg, JL Dienstag - Clinics in liver disease, 1999 - Elsevier Alpha interferon has been the mainstay of treatment for chronic hepatitis B
since its introduction in the mid-1980s, but only approximately 30% to 40% of
patients respond to this therapy. 17 Interferon's principal mechanism of ... Cited by 26 - Related articles - BL Direct
P Martin, MA Edetstein, SHB Han - Management of Chronic Viral Hepatitis, 2001 - books.google.com Current Treatment of Chronic Hepatitis B Paul Martin University of California at
Los Angeles School of Medicine and Cedars-Sinai Medical Center Los Angeles,
California Marc A. Edetstein and Steven-Huy B. Han University of California ... Related articles - BL Direct
E Schiff, S Karayalcin, I Grimm, R Perillo, J … - Hepatology, 1998 - muni.cz On selecting a constituent part of MU the "Overview of publishing activities"
page will be displayed with information relevant to the selected constituent
part. The "Overview of publishing activities" page is not available for non- ... Cited by 115 - Related articles - Cached - All 2 versions
B Jarvis, D Faulds - Drugs, 1999 - ingentaconnect.com A Review of its Therapeutic Potential in Chronic Hepatitis B ... Various
sections of the manuscript reviewed by: P. Andreone, Ambulatorio di Epatologia,
Servizio di Semeiotica Medica, Università di Bologna, Bologna, Italy; M. ... Cited by 119 - Related articles - BL Direct - All 3 versions
MV Galan, SC Gordon, D Boyce - eop, 2001 - informahealthcare.com Chronic infection with the hepatitis B virus (HBV) affects 350 million people
worldwide, or approximately 5% of the global population, and commonly results in
cirrhosis and hepatocellular carcinoma. Until recently, the only available ... Cited by 22 - Related articles - All 4 versions
F Yao, RG Gish - Current Gastroenterology Reports, 1999 - Springer Introduction Chronic infection with the hepatitis B virus (HBV) affects over 300
million people throughout the world and over 1 million individuals in the United
States [1,2]. More than 75% of HBV-infected individuals reside in Asia, ... Cited by 6 - Related articles - All 3 versions
